Content
All Posts > Content under Healthcare
Putting Gilead’s 10% Dividend Increase Under The Microscope
Article By:
SureDividend
Read
Wednesday, February 15, 2017 11:48 AM EDT
While healthcare stocks with the longest track records of dividend increases are usually diversified companies like Johnson & Johnson, Gilead is an attractive stock for a solid 3% yield and high dividend growth.
Gilead Sciences Is Now More Attractive After Showing Superior Results Of Its Newest HIV Drug
Article By:
Arie Goren
Read
Wednesday, February 15, 2017 5:09 AM EDT
Gilead's stock is extremely undervalued, and it still has high growth prospects due to new revolutionary drugs in its pipeline and a possible big acquisition. The average target price of the top analysts is at $84.17, an upside of 24.6%.
Express Scripts Holding Company Q1 Outlook Underwhelms After Mixed Q4 Results
Article By:
Lorimer Wilson
Read
Wednesday, February 15, 2017 4:53 AM EDT
The St. Louis-based pharmacy benefits manager reported adjusted Q4 EPS $1.88, which was $0.01 better than Wall Street consensus estimate of $1.87. Revenues fell 5% from last year to $24.86 billion, missing analysts’ expectation of $26.29 billion.
Some Quick Thoughts On VistaGen
Article By:
Jason Napodano
Read
Wednesday, February 15, 2017 1:04 AM EDT
On February 13, 2017, VistaGen Therapeutics provided a business and financial update following results of the quarter ending December 31, 2016. Here is a quick review of some of the recent happenings at the company.
Four Consecutive Trading Sessions With Record Highs
Article By:
Marvin R Clark
Read
Tuesday, February 14, 2017 11:31 PM EDT
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Inovio Inks New Deal With ApolloBio Corporation
Article By:
KKD Healthcare Analytics
Read
Tuesday, February 14, 2017 12:31 PM EDT
Inovio Pharmaceuticals Inc. announced its new collaboration with ApolloBio Corporation.
In this article: INO
Three Stocks To Buy For Valentine’s Day
Video By:
Charles Sizemore
Watch
Tuesday, February 14, 2017 10:53 AM EDT
European stocks have mostly traded sideways for years, and LVMH is no exception. This stock is a play on a bounce in the euro, on European stocks in general and on an recovery in China, the world’s largest luxury consumer.
Best And Worst Large Cap Stocks To Buy - Tuesday, Feb. 14
Article By:
E.B. Capital Markets
Read
Tuesday, February 14, 2017 10:16 AM EDT
The average score in our large cap universe is 69.77. Over the past four weeks, the average large cap score is 66.57. Average large cap scores are approaching levels consistent with being overbought.
Cynosure, Inc. To Be Acquired By Hologic, Inc. For $66/Share In Cash, Or $1.65 Bln
Article By:
Lorimer Wilson
Read
Tuesday, February 14, 2017 9:33 AM EDT
Cynosure’s portfolio includes over 20 products across major categories, including non-invasive body contouring, hair removal, skin revitalization, and women’s health. Cynosure’s products are currently sold in over 130 countries.
Aetna, Humana Mutually End Merger Agreement
Allergan To Acquire Zeltiq Aesthetics For $2.48B, $56.50 Per Share
Article By:
Jacob Maslow
Read
Tuesday, February 14, 2017 6:39 AM EDT
Allergan announced on Monday that the company will acquire Zeltiq Aesthetics in a $2.48 billion deal. The company's failed merger with Pfizer Inc. last year has led to Allergen Chief Executive Brent Saunders acquiring several companies.
Swing Traders Win Big On Small Cap Stock Trades - CERU PXLW BIOC
Video By:
Swing Trade Warrior
Watch
Tuesday, February 14, 2017 5:30 AM EDT
BIOC was first of the swing trade win streak. Long entry was alerted on 2/08/17. Profits were taken on 2/9/17 for a total ROI of 31%.
Wall Street Hit Record Highs Again
Article By:
Marvin R Clark
Read
Monday, February 13, 2017 11:56 PM EDT
Wall Street hit record highs again. Stock markets around the world were higher this morning. The S&P 500’s market value topped $20 trillion.